Papatheodoridis, G. Et Al. 2014. PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF. EASL 49th Annual Meeting of the International Liver Meeting .

Papatheodoridis, G., Dalekos, G., Sypsa, V., YURTAYDIN, S. C., Buti, M., Goulis, J., ... Arends, P.(2014). PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF . EASL 49th Annual Meeting of the International Liver Meeting

Papatheodoridis, ONUR Et Al. "PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF," EASL 49th Annual Meeting of the International Liver Meeting, 2014

Papatheodoridis, ONUR Et Al. "PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF." EASL 49th Annual Meeting of the International Liver Meeting , 2014

Papatheodoridis, G. Et Al. (2014) . "PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF." EASL 49th Annual Meeting of the International Liver Meeting .

@conferencepaper{conferencepaper, author={ONUR KESKİN Et Al. }, title={PAGE B RISK SCORE FOR HEPATOCELLULAR CARCINOMA HCC DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B CHB PATIENTS RECEIVING ENTECAVIR ETV OR TENOFOVIR TDF}, congress name={EASL 49th Annual Meeting of the International Liver Meeting}, city={}, country={}, year={2014}}